The physiology, pathology, and potential therapeutic applications of the TREM2 signaling pathway

A Deczkowska, A Weiner, I Amit - Cell, 2020 - cell.com
Alzheimer's disease, obesity-related metabolic syndrome, and cancer are the leading
causes of death and among the most costly medical conditions in the Western world. In all …

[HTML][HTML] Soluble TREM2: Innocent bystander or active player in neurological diseases?

F Filipello, C Goldsbury, SF You, A Locca… - Neurobiology of …, 2022 - Elsevier
Triggering receptor expressed on myeloid cells 2 (TREM2) is an innate immune receptor
expressed by macrophages and microglia in the central nervous system (CNS). TREM2 has …

Systematic assessment of 10 biomarker candidates focusing on α‐synuclein‐related disorders

I Schulz, N Kruse, RG Gera, T Kremer… - Movement …, 2021 - Wiley Online Library
Background Objective diagnostic biomarkers are needed to support a clinical diagnosis.
Objectives To analyze markers in various neurodegenerative disorders to identify diagnostic …

Translational molecular imaging and drug development in Parkinson's disease

A Haider, NH Elghazawy, A Dawoud… - Molecular …, 2023 - Springer
Parkinson's disease (PD) is a progressive neurodegenerative disorder that primarily affects
elderly people and constitutes a major source of disability worldwide. Notably, the …

Performance of a fully-automated Lumipulse plasma phospho-tau181 assay for Alzheimer's disease

EN Wilson, CB Young, J Ramos Benitez… - Alzheimer's Research & …, 2022 - Springer
Background The recent promise of disease-modifying therapies for Alzheimer's disease
(AD) has reinforced the need for accurate biomarkers for early disease detection, diagnosis …

[HTML][HTML] Quantifying cerebrospinal fluid dynamics: a review of human neuroimaging contributions to CSF physiology and neurodegenerative disease

NH Mehta, RA Suss, JP Dyke, ND Theise… - Neurobiology of …, 2022 - Elsevier
Cerebrospinal fluid (CSF), predominantly produced in the ventricles and circulating
throughout the brain and spinal cord, is a key protective mechanism of the central nervous …

TREM1 disrupts myeloid bioenergetics and cognitive function in aging and Alzheimer disease mouse models

EN Wilson, C Wang, MS Swarovski, KA Zera… - Nature …, 2024 - nature.com
Human genetics implicate defective myeloid responses in the development of late-onset
Alzheimer disease. A decline in peripheral and brain myeloid metabolism, triggering …

Distinct myeloid population phenotypes dependent on TREM2 expression levels shape the pathology of traumatic versus demyelinating CNS disorders

H Gao, J Di, BH Clausen, N Wang, X Zhu, T Zhao… - Cell reports, 2023 - cell.com
Triggering receptor expressed on myeloid cell 2 (TREM2) signaling often drives opposing
effects in traumatic versus demyelinating CNS disorders. Here, we identify two distinct …

Soluble TREM2 triggers microglial dysfunction in neuromyelitis optica spectrum disorders

C Qin, M Chen, MH Dong, S Yang, H Zhang, YF You… - Brain, 2024 - academic.oup.com
Microglia-mediated neuroinflammation contributes to acute demyelination in neuromyelitis
optica spectrum disorders (NMOSD). Soluble triggering receptor expressed on myeloid cells …

Limited proteolysis–mass spectrometry reveals aging-associated changes in cerebrospinal fluid protein abundances and structures

SR Shuken, J Rutledge, T Iram, PM Losada, EN Wilson… - Nature Aging, 2022 - nature.com
Cerebrospinal fluid (CSF) proteins and their structures have been implicated in aging and
neurodegenerative diseases. In the present study, we used limited proteolysis–mass …